相关实验视频

Updated: Jun 18, 2025

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

微RNA工程外体在糖尿病伤口愈合中的治疗潜力:一个元分析

Xichao Jian¹, Jiansu Han¹, Junzhe Chen¹

¹Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, Guizhou, P. R. China.

Archives of dermatological research

|July 27, 2024

概括

微RNA工程外体 (miR-exo) 通过增强组织修复和减少炎症显著改善糖尿病伤口愈合. 这一元分析证实了它们的有效性,表明了先进伤口护理策略的潜力.

科学领域:

再生医学是一种再生医学.
生物技术是生物技术.
糖尿病并发症研究研究研究

背景情况:

糖尿病伤口由于受损的愈合过程,代表着重大的临床挑战.
微RNA工程外体 (miR-exo) 已成为糖尿病伤口管理的潜在治疗策略.
在糖尿病伤口愈合中的miR-exo疗效背后的精确机制需要进一步阐明.

研究的目的:

进行一项元分析,评估微RNA工程外体 (miR-exo) 在糖尿病伤口管理中的治疗疗效.
综合现有关于miR-exo治疗对关键伤口愈合参数的影响的证据.

主要方法:

在PubMed,Embase,Web of Science和Cochrane图书馆进行了系统的文献搜索,截至2023年7月4日.
涉及72只动物的6项研究符合分析的纳入标准.
结果指标包括伤口愈合率,新血管化,再上皮化,原沉积,痕宽度和炎症因素.

主要成果:

分析表明,miR-exo治疗在促进糖尿病伤口愈合方面显著优于对照疗法.
miR-exo显著提高了伤口愈合率,新血管化,再上皮化和原沉积.
用miR-exo治疗导致痕宽度显著减少,并降低了炎症因素的调节.

结论:

微RNA工程外体 (miR-exo) 有效地增强糖尿病伤口愈合,特别是当与先进的带相结合时.
进一步的大规模,双盲临床试验和长期随访是有必要的,以优化miR-exo治疗参数.

关键词:

糖尿病患者糖尿病患者进行元分析分析.微RNA工程外体的外体是微RNA工程外体.伤口愈合伤口愈合

更多相关视频

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model

Creation and Transplantation of an Adipose-derived Stem Cell ASC Sheet in a Diabetic Wound-healing Model

Published on: August 4, 2017

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...